Over the past two decades, regulation of the activity of neurotrophinreceptors, and the brain-derived neurotrophic factor (BDNF) in particular, hasbeen viewed as a new strategy for treating neurodegenerative diseases. This evidence concerns the gene BDNF and neurodegenerative disease.